Mon Dec 13, 2021 – 1:35 pm EST
(LifeSiteNews) — The U.S. Food and Drug Administration (FDA) approved the mRNA Pfizer COVID jab booster for use in teenagers aged 16 and 17 Thursday.
In its authorization, the FDA sidestepped consulting its Vaccines and Related Biological Products Advisory Committee (VRBPAC), an independent body of vaccine advisors, admitting in its December 9 press release that the FDA purposely did not meet with the committee.
“[The] agency previously convened the committee for extensive discussions regarding the use of booster doses of COVID-19 vaccines and, after review of Pfizer’s EUA [emergency use authorization] request, the FDA concluded that the request does not raise questions that would benefit from additional discussion by committee members.”
Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said that the effectiveness of the Pfizer jab, which has had EUA since December 2020, “is waning after the second dose of the vaccine for all adults and for those in the 16- and 17-year-old age group.” He added that a “single booster dose of the vaccine for those vaccinated at least six months prior will help provide continued protection against COVID-19 in this and older age groups.”
However, the push to vaccinate the majority of
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
